Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on MarCom Europe.
Press releases published on August 7, 2025
NCS Multistage Holdings, Inc. to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 7, 2025
HOUSTON, Aug. 07, 2025 (GLOBE NEWSWIRE) -- NCS Multistage Holdings, Inc. (“NCS” or the “Company”) (NASDAQ:NCSM) announced today that Ryan Hummer, Chief Executive Officer, is scheduled to present in the following upcoming investor conferences: EnerCom …
Nutanix Announces Date and Conference Call Information for Fiscal Fourth Quarter and Fiscal Year 2025 Financial Results
GlobeNewswire
·
August 7, 2025
SAN JOSE, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Nutanix, Inc. (NASDAQ: NTNX), a leader in hybrid multicloud computing, today announced that it will report its financial results for the fiscal fourth quarter and fiscal year 2025, which ended July 31, …
Crinetics Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 7, 2025
Regulatory Interactions and Commercial, Medical and Corporate Preparations On-Track for PALSONIFY™ (paltusotine) New Drug Application with September 25, 2025 PDUFA Date Continued Progress on the Global Development Program for Atumelnant Across …
Regeneron Announces Investor Conference Presentations
GlobeNewswire
·
August 7, 2025
TARRYTOWN, N.Y., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: Cantor Global Healthcare Conference 2025 at 1:35 p.m. ET on Wednesday, September 3, 2025 2025 Wells Fargo …
Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to September 9, 2025
GlobeNewswire
·
August 7, 2025
New York, NY, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Globalink Investment Inc. (OTC Pink: GLLI, GLLIW, GLLIR, GLLIU) (“Globalink” or the “Company”), a special purpose acquisition company, announced today that on August 5, 2025, it caused to be deposited $0.15 …
CarGurus Announces Second Quarter 2025 Results & Shares Plans to Wind Down CarOffer Transactions Business
GlobeNewswire
·
August 7, 2025
Sustained strong momentum in the Marketplace business, with revenue up 14% YoY Q2'25 Net Income of $22.3 million; Non-GAAP Adjusted EBITDA of $77.3 million, up 39% YoY Board approves additional $150 million share repurchase, increasing 2025 authorization …
Karat Packaging Reports 2025 Second Quarter Financial Results
GlobeNewswire
·
August 7, 2025
-- Record Quarterly Net Sales and Net Income -- -- Successful Alternative Sourcing to Navigate Tariff Uncertainty -- CHINO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Karat Packaging Inc. (Nasdaq: KRT) (“Karat” or the “Company”), a specialty distributor …
Sight Sciences Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance
GlobeNewswire
·
August 7, 2025
MENLO PARK, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform …
Commerce to Host Sell-side Analyst Q&A Session at Upcoming BigSummit
GlobeNewswire
·
August 7, 2025
AUSTIN, Texas, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Commerce.com, Inc. (Nasdaq: CMRC) (formerly BigCommerce Holdings, Inc.), a provider of an open, intelligent ecosystem of technology solutions that empower businesses to unlock data potential and deliver …
Concentrix to Present at Upcoming Investor Conferences
GlobeNewswire
·
August 7, 2025
NEWARK, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Concentrix Corporation (NASDAQ: CNXC), a global technology and services leader, today announced that members of its senior executive team will be participating in the following upcoming conferences: …
Interpace Biosciences Announces Second Quarter 2025 Financial and Business Results
GlobeNewswire
·
August 7, 2025
● Q2 Revenue of $9.2 million ● Q2 Cash Collections of $10.8 million ● Q2 Thyroid test volume up 16% year-over-year to record levels ● Q2 Thyroid revenue of $8.7M; up 25% year-over-year to record levels PARSIPPANY, NJ, Aug. 07, 2025 (GLOBE NEWSWIRE) …
Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 7, 2025
Phase 2b NAVIGATE clinical trial evaluating CD388 for the prevention of seasonal influenza met primary and all secondary efficacy endpoints for all dose groups End of Phase 2 meeting request submitted to the U.S. Food and Drug Administration (FDA) Closed …
IMAC Holdings Announces Research Collaboration with Vanderbilt University Medical Center to Advance Immuno-Oncology Biomarker Discovery
GlobeNewswire
·
August 7, 2025
Project will leverage Ignite Proteomics’ reverse-phase protein array (RPPA) platform to profile tumor-immune signaling in breast-cancer samples Golden, CO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc. (OTCQB: …
Key Tronic Corporation Announces Fourth Quarter Reporting and Annual Meeting Date
GlobeNewswire
·
August 7, 2025
SPOKANE VALLEY, Wash., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Key Tronic Corporation (Nasdaq: KTCC), announced today that it plans to report its results for the fourth quarter and full year ended of fiscal 2025 after market close on August 27, 2025. Key Tronic …
Galapagos Creates New Subscription Right Plan
GlobeNewswire
·
August 7, 2025
Mechelen, Belgium; August 7, 2025, 22.01 CET; regulated information – Galapagos NV (Euronext …
Galapagos creëert nieuw inschrijvingsrechtenplan
GlobeNewswire
·
August 7, 2025
Mechelen, België; 7 augustus 2025, 22.01 CET; gereglementeerde informatie – Galapagos NV (Euronext …
Belpointe OZ’s Aster & Links Wins Two Awards
GlobeNewswire
·
August 7, 2025
SARASOTA, FL, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Belpointe PREP, LLC (“Belpointe OZ,” “we,” “us,” “our” or the “Company”), the first and only publicly traded Qualified Opportunity Fund (NYSE American: OZ), is proud to announce that its flagship development, …
Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2025 Financial Results
GlobeNewswire
·
August 7, 2025
Announced positive topline results from registrational STAAR study in Fabry disease, including positive mean annualized estimated glomerular filtration rate (eGFR) slope at 52-weeks across all dosed patients in the study, which U.S. Food and Drug …
Treace Medical to Host Investor Day Highlighting New Products on September 3, 2025
GlobeNewswire
·
August 7, 2025
PONTE VEDRA, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, …
Research Frontiers Reports Second Quarter 2025 Financial Results and Will Host a Conference Call at 4:30p.m. Today
GlobeNewswire
·
August 7, 2025
WOODBURY, N.Y., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its second quarter of 2025. Management will host a conference call today at 4:30 p.m. Eastern Time to discuss its financial and …